# Esmolol increases the fecal abundance of Lactobacillus in a rat model of sepsis

**Authors:** Bo Yao, Fu-hua Wang, Xiao-ning Han, Jun Yang, Ping Xue, Qi Qi, Guang-yao Wei, Jin-yan Xing

PMC · DOI: 10.1186/s40635-023-00589-1 · Intensive Care Medicine Experimental · 2024-03-04

## TL;DR

Esmolol increases Lactobacillus in rat feces during sepsis and reduces harmful nitric oxide levels.

## Contribution

Esmolol's effect on gut microbiome and nitric oxide in sepsis is newly demonstrated in a rat model.

## Key findings

- Esmolol increased Lactobacillus abundance in septic rats.
- Esmolol reduced iNOS expression and nitric oxide concentration in colon feces.
- Lactobacillus was predominant in esmolol-treated septic rats.

## Abstract

Disorders of the gut microbiome could be responsible for the progression of multiple organ dysfunction syndrome. In this study, we examined the effect of esmolol on the gut microbiome in a rat model of sepsis induced by cecal ligation and puncture (CLP).

The animals (n = 32) were randomly divided into 3 groups: Sham group (sham operation + normal saline treatment, n = 8), CLP group (cecal ligation and puncture + normal saline treatment, n = 12), and CLP + ESM group (cecal ligation and puncture + esmolol treatment, n = 12). After 24 h, feces in the colon were collected for 16S rRNA gene sequencing and nitric oxide analysis. In addition, colon was removed for immunohistochemical staining of inducible nitric oxide synthase (iNOS).

Four rats in the CLP group and two rats in the CLP + ESM group died. The abundance of Lactobacillus in the CLP + ESM group was higher than CLP group (P = 0.048). In the linear discriminant analysis effect size analysis, Norank f Muribaculaceae, Escherichia–Shigella and Lactobacillus were the predominant bacteria in the Sham group, CLP group and CLP + ESM group, respectively. The iNOS expression in colonocytes stained by brown in the CLP group were much more than Sham group (P = 0.001). Compared to CLP group, the iNOS expression in colonocytes reduced after esmolol treatment (P = 0.013). The concentration of nitric oxide in colon feces was different in Sham group, CLP group and CLP + ESM group (1.31 ± 0.15μmmol/l vs. 1.98 ± 0.27μmmol/l vs. 1.51 ± 0.14μmmol/l, P = 0.001). In addition, the concentration of nitric oxide in CLP group was higher than Sham group (P = 0.001) or CLP + ESM group (P = 0.001).

Esmolol increased the fecal abundance of Lactobacillus in a rat model of sepsis. Moreover, esmolol reduced the iNOS expression of colonocytes and the nitric oxide concentration of colon feces.

## Linked entities

- **Proteins:** NOS2 (nitric oxide synthase 2)
- **Chemicals:** esmolol (PubChem CID 59768), nitric oxide (PubChem CID 145068)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Nos2 (nitric oxide synthase 2) [NCBI Gene 24599] {aka Nos2a, iNos}
- **Diseases:** sepsis (MESH:D018805), multiple organ dysfunction syndrome (MESH:D009102)
- **Chemicals:** ESM (-), Esmolol (MESH:C036604), nitric oxide (MESH:D009569)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Lactobacillus (genus) [taxon 1578]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10909807/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10909807/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC10909807/full.md

---
Source: https://tomesphere.com/paper/PMC10909807